Andover, Mass.
Tokyo, Japan-based drugmaker Eisai Co. is planning to begin construction in early 2004 on a $65-million R&D center in Andover, Mass. The facility will enable Eisai to double its U.S. basic research staff to as many as 170 employees. Eisai will also spend approximately $9-million on a second production line for drugs used in clinical testing at one of its existing U.S. research facilities.
